This account will no longer be monitored or updated - please join us over on @LinkedIn for all the latest Birmingham Health Partners news: https://t.co/WhEHZ9hHhH
Meet 15-year-old Finnan Boonak, one of the first patients in the UK who is taking part in a research trial which will help to ease symptoms of his rare disease.
Find out more about his condition and the trial by heading to our website.
#RareDiseaseDay
🩸 How do you deliver life-saving blood to patients over long distances, in extreme heat, with no reliable refrigeration? Samoco is developing a drone-ready smart transport device to keep blood cool and protected, now being prototyped at PHTA’s Makerspace:
https://t.co/Yd7nbKy56S
Immensely honoured to receive the 2026 Dorothy Hodgkin Medal for Research Excellence (Clinical) from the Society for Endocrinology. Grateful to the so many who inspired me and to the very many who I had the joy to work with during this journey! @BHPComms@Soc_Endo@unibirm_CMH
#RareDiseaseDay | The first participant was recently treated in a @unibirmingham trial investigating whether a new medical device can slow disease progression for patients with a rare liver disease. @BirminghamBRC@UoBinfectionsch
📎 Read more: https://t.co/iqsgLIp5Hw
#RareDiseaseDay | The @lifearc1 Centre for Acceleration of Rare Disease Trials aims to speed up the time it takes for rare disease treatments to reach those who need them.
A consortium between @unibirmingham@QUBelfast@UniofNewcastle.
📎 Learn more: https://t.co/GC67bFFiM2
#RareDiseaseDay | Prof Amos Burke was recently appointed as the first @LPTrustUK funded Chair of Paediatric Oncology at @unibirmingham, aiming to accelerate the development of childhood cancer treatments through research and clinical trials.
📎 Read more: https://t.co/DO3FItgrRP
Our first NIHR Birmingham BRC newsletter lands tomorrow! 🚨
Sign up now to get research news, events and updates straight to your inbox: https://t.co/ErNQOM23WC
Are you involved or interested in health data research?
If yes, you are invited to the West Midlands Secure Data Environment Stakeholder Summit on 24 March to find out how it supports AI data research, genomics and much more!
Register: https://t.co/h9TQxxWtOz
🔥|Anti-#cancer collaboration with @ROHNHSFT secures a place on SPARK THE MIDLANDS scheme
💉Will help develop minimally invasive anti-cancer & #bone regenerative injectable paste
🩻Could be used to treat primary & metastatic cancer
👉https://t.co/rziMmsIQW7 @AstonEPS
Can treating gum disease help improve rheumatoid arthritis? New research from @unibirmingham shows a two-way inflammatory cycle between #RA and #Periodontitis — and that periodontal therapy can significantly improve RA disease scores.
🔗Read more: https://t.co/zVdyLL5szb
In this video, Richard Meddings CBE, Chair of @BHPComms, outlines an inspiring vision for BHP strengthening care, reducing inequalities and improving health across our communities.
As a BHP partner, HIWM is delighted to support and contribute to this shared mission.
🩻 A UK-first trial led by Birmingham researchers aims to improve treatment of arthritis in people who have developed the condition as a result of cancer immunotherapy ⬇️
https://t.co/c3wNGqUtZ5 @BirminghamBRC@CRCTU
Final places available 🚀
Our first PHTA Founder Growth Series workshop focuses on sales management for early-stage life science founders: practical tools + clear processes = real growth.
🗓️ 26 Feb | 🕑 2–5pm
Register: https://t.co/lz61I0D1pm
Our researchers are leading the way on improving cancer treatment recovery in older people, through a new study aimed at keeping people well for longer. REBOUND is examining key hallmarks of ageing, and how they're affected by treatment in people aged 65+
https://t.co/qofCBhxp9h
Why do so many promising pancreatic cancer treatments fail in the lab? The answer has been uncovered by researchers at @unibirmingham, @uhbtrust & industry partner @bmsnews - creating a roadmap for discovering therapies more effectively:
https://t.co/WEAaIsHr02 @ShivanSivakumar
👁️ Patients with Idiopathic Intracranial Hypertension (#IIH), which causes debilitating headaches and potential sight loss, are invited to self-refer to a new @unibirmingham & @Specsavers trial, assessing the impact of #Mounjaro on their condition ⬇️https://t.co/maLXrXDNPo
👩🔬 Selly Oak teens can now explore the world of medical innovation thanks to our partnership with local schools, convened by @AlistairCarns MP. Students can learn skills from device design & development to materials science in our medtech Makerspace⬇️⬇️
https://t.co/LKPjOhX1uQ
A new @unibirmingham trial delivered through our BRC is testing whether weight‑loss drug Mounjaro (Tirzepatide) can help treat Idiopathic Intracranial Hypertension, a condition that can cause severe headaches and sight loss.
🔗 Find out more: https://t.co/MBVqWwftOS
Last week, we brought together researchers, clinicians, patient & public contributors and partners from across the West Midlands to collaboratively shape the future strategy of our BRC.
Thank you to all attendees for your valuable insights!
Read more: https://t.co/YiZDA7YExQ